Remove Cardiovascular Disease Remove Drug Costs Remove Medicaid
article thumbnail

Trends in direct health care costs among US adults with atherosclerotic cardiovascular disease with and without diabetes

Cardiovascular Diabetology

Objective Population-based national data on the trends in expenditures related to coexisting atherosclerotic cardiovascular diseases (ASCVD) and diabetes is scarce. A key driver of the observed increase in direct costs was prescription drug costs, which increased by 37% among all individuals with ASCVD.